Properties (91)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
gptkb:Inozyme_Pharma
gptkb:Sangamo_Therapeutics |
| gptkbp:CEO |
gptkb:Matthijs_C._E._(Mat)_van_der_Meer
|
| gptkbp:clinicalTrials |
gptkb:Hemophilia_B
gptkb:Germ_cell_tumors gptkb:Gaucher_disease gptkb:Tay-Sachs_disease gptkb:Wiskott-Aldrich_syndrome gptkb:Mucopolysaccharidosis_type_II gptkb:Mucopolysaccharidosis_type_IV gptkb:Fabry_disease gptkb:Mucopolysaccharidosis_type_III gptkb:Duchenne_muscular_dystrophy gptkb:Non-Hodgkin_lymphoma gptkb:Hyper-IgM_syndrome gptkb:Canavan_disease gptkb:Mucopolysaccharidosis_type_I gptkb:Liposarcoma gptkb:Friedreich's_ataxia gptkb:Huntington's_disease Multiple sclerosis Neuroblastoma Hodgkin lymphoma Parkinson's disease Sickle cell disease Thalassemia Cystic fibrosis Acute lymphoblastic leukemia Tumor microenvironment Ataxia-telangiectasia Phase 3 Chronic pain Chondrosarcoma Osteosarcoma Acute myeloid leukemia Chronic myeloid leukemia Usher syndrome Pompe disease Leber congenital amaurosis Retinitis pigmentosa Multiple myeloma Spinal muscular atrophy Wilms tumor Retinoblastoma Myelodysplastic syndromes Phase 1/2 Mucopolysaccharidosis type VI X-linked severe combined immunodeficiency Fanconi anemia Aplastic anemia Ewing sarcoma Adenosine deaminase deficiency Adult tumors Alpha-1 antitrypsin deficiency Chronic granulomatous disease Chronic lymphocytic leukemia Common variable immunodeficiency Cyclic neutropenia Diamond-Blackfan anemia Mucopolysaccharidosis type VII Pediatric tumors Rhabdomyosarcoma Severe combined immunodeficiency Severe congenital neutropenia Soft tissue sarcoma X-linked agammaglobulinemia Hemoglobinopathies |
| gptkbp:collaborations |
gptkb:Harvard_University
gptkb:Stanford_University gptkb:University_of_Pennsylvania |
| gptkbp:focus |
gene therapy
|
| gptkbp:founded |
1991
|
| gptkbp:headquarters |
Amsterdam,_Netherlands
|
| https://www.w3.org/2000/01/rdf-schema#label |
uniQure N.V.
|
| gptkbp:investmentFocus |
gptkb:New_Enterprise_Associates
gptkb:Frazier_Healthcare_Partners OrbiMed Advisors |
| gptkbp:market |
$1.5 billion (2021)
|
| gptkbp:numberOfEmployees |
100-200
|
| gptkbp:partnerships |
gptkb:Bristol-Myers_Squibb
Regenxbio |
| gptkbp:patentCitation |
gene therapy patents
AAV_technology_patents |
| gptkbp:products |
gptkb:Glybera
AMT-061 |
| gptkbp:researchFocus |
AAV_vector_technology
|
| gptkbp:revenue |
$50 million (2020)
|
| gptkbp:stockSymbol |
QURE
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
www.uniqure.com
|